As of June 17, 2025, Thermo Fisher Scientific Inc (TMO) reports a Current Ratio of 1.66.
Current Ratio assesses a company's ability to pay short-term debts by comparing liquid assets to liabilities, with higher ratios signaling better financial health.
Historical Trend of Thermo Fisher Scientific Inc's Current Ratio
Over recent years, Thermo Fisher Scientific Inc's Current Ratio has shown a moderate pattern. The table below summarizes the historical values:
| Date | Current Ratio |
|---|---|
| 2024-12-31 | 1.66 |
| 2023-12-31 | 1.75 |
| 2022-12-31 | 1.48 |
| 2021-12-31 | 1.50 |
| 2020-12-31 | 2.13 |
This slight upward trend highlights how Thermo Fisher Scientific Inc manages its short-term assets and liabilities over time.
Comparing Thermo Fisher Scientific Inc's Current Ratio to Peers
To better understand Thermo Fisher Scientific Inc's position, it's useful to compare its Current Ratio against industry peers. Below are selected comparisons:
| Company | Current Ratio |
|---|---|
| Thermo Fisher Scientific Inc (TMO) | 1.66 |
| Seer Inc (SEER) | 16.53 |
| Quanterix Corp (QTRX) | 8.67 |
| Repligen Corp (RGEN) | 8.41 |
| Immunoprecise Antibodies Ltd (IPA.V) | 8.05 |
| Maravai LifeSciences Holdings Inc (MRVI) | 7.53 |
Compared to its competitors, Thermo Fisher Scientific Inc's Current Ratio is about average compared to peers, reflecting balanced short-term asset management.